CDKN2B and coronary artery disorder: LncRNA cyclin-dependent kinase inhibitor 2B antisense RNA 1 (CDKN2B-AS1), also known as ANRIL, has been reported to be predominately expressed in tissues associated with coronary heart disease including cardiac, vascular endothelial cells and human monocyte-derived macrophages [9].